UpdateApril 30, 20261 min read
FDA Revolutionizes Clinical Trials with AI-Powered Real-Time Monitoring
The US Food and Drug Administration is launching a groundbreaking pilot program to monitor clinical trials in real-time using AI and cloud computing, aiming to slash drug approval times by up to 40%. This move marks a significant shift in the agency's approach to clinical trials, leveraging cutting-edge technology to streamline the process and bring new treatments to market faster.
The FDA is launching a pilot program to monitor clinical trials in real time using AI and cloud computing, a move the agency says could dramatically shorten the time it takes to approve new drugs. The article FDA bets on AI and cloud monitoring for clinical trials as it looks to rebuild after DOGE layoffs appeared first on The Decoder.